Search the collection

23 results for Selmaj,+Krzysztof+W

Sort by:

Sort by

Limit results to:

20 per page

23 results for Selmaj,+Krzysztof+W

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
microRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination
Author / Creator:Mycko, Marcin P. ; Cichalewska, Maria ; Machlanska, Agnieszka ; Cwiklinska, Hanna ; Mariasiewicz, Magdalena ; Selmaj, Krzysztof W.
Publisher:United States: National Academy of Sciences
Journal title:Proceedings of the National Academy of Sciences - PNAS, 2012-05, Vol.109 (20), p.7600-7601
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Author / Creator:Coles, Alasdair J, Dr ; Twyman, Cary L, MD ; Arnold, Douglas L, Prof ; Cohen, Jeffrey A, Prof ; Confavreux, Christian, Prof ; Fox, Edward J, MD ; Hartung, Hans-Peter, Prof ; Havrdova, Eva, Prof ; Selmaj, Krzysztof W, Prof ; Weiner, Howard L, Prof ; Miller, Tamara, MD ; Fisher, Elizabeth, PhD ; Sandbrink, Rupert, MD ; Lake, Stephen L, ScD ; Margolin, David H, MD ; Oyuela, Pedro, MD ; Panzara, Michael A, MD ; Compston, D Alastair S, Prof
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2012-11, Vol.380 (9856), p.1829-1839
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Author / Creator:Cohen, Jeffrey A, Prof ; Coles, Alasdair J, PhD ; Arnold, Douglas L, Prof ; Confavreux, Christian, Prof ; Fox, Edward J, MD ; Hartung, Hans-Peter, Prof ; Havrdova, Eva, Prof ; Selmaj, Krzysztof W, Prof ; Weiner, Howard L, Prof ; Fisher, Elizabeth, PhD ; Brinar, Vesna V, MD ; Giovannoni, Gavin, Prof ; Stojanovic, Miroslav, MD ; Ertik, Bella I, MD ; Lake, Stephen L, ScD ; Margolin, David H, MD ; Panzara, Michael A, MD ; Compston, D Alastair S, Prof
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2012-11, Vol.380 (9856), p.1819-1828
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
Author / Creator:Cohen, Jeffrey A, Dr ; Arnold, Douglas L, MD ; Comi, Giancarlo, MD ; Bar-Or, Amit, MD ; Gujrathi, Sheila, MD ; Hartung, Jeffrey P, PhD ; Cravets, Matt, MA ; Olson, Allan, MD ; Frohna, Paul A, MD ; Selmaj, Krzysztof W, MD
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2016-04, Vol.15 (4), p.373-381
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
Author / Creator:Coles, Alasdair J. ; Arnold, Douglas L. ; Bass, Ann D. ; Boster, Aaron L. ; Compston, D. Alastair S. ; Fernández, Óscar ; Havrdová, Eva Kubala ; Nakamura, Kunio ; Traboulsee, Anthony ; Ziemssen, Tjalf ; Jacobs, Alan ; Margolin, David H. ; Huang, Xiaobi ; Daizadeh, Nadia ; Chirieac, Madalina C. ; Selmaj, Krzysztof W.
Publisher:London, England: SAGE Publications
Journal title:Therapeutic advances in neurological disorders, 2021, Vol.14, p.1756286420982134-1756286420982134
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
Author / Creator:Coles, Alasdair J, MD ; Fox, Edward, MD ; Vladic, Anton, MD ; Gazda, Suzanne K, MD ; Brinar, Vesna, MD ; Selmaj, Krzysztof W, MD ; Bass, Ann Doan-Do, DO ; Wynn, Daniel R, MD ; Margolin, David H, MD ; Lake, Stephen L, ScD ; Moran, Susan, MD ; Palmer, Jeffrey, MS ; Smith, M Shelton, PhD ; Compston, D Alastair S, MD
Publisher:London: Elsevier Ltd
Journal title:Lancet neurology, 2011-04, Vol.10 (4), p.338-348
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
Author / Creator:Comi, Giancarlo ; Kappos, Ludwig ; Selmaj, Krzysztof W ; Bar-Or, Amit ; Arnold, Douglas L ; Steinman, Lawrence ; Hartung, Hans-Peter ; Montalban, Xavier ; Kubala Havrdová, Eva ; Cree, Bruce A C ; Sheffield, James K ; Minton, Neil ; Raghupathi, Kartik ; Ding, Ning ; Cohen, Jeffrey A
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2019-11, Vol.18 (11), p.1009-1020
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis
Author / Creator:Dubinsky, Marla C ; Charles, Lorna ; Selmaj, Krzysztof W ; Comi, Giancarlo ; Krakovich, Anthony ; Rosen, Melissa ; van der Woude, C Janneke ; Mahadevan, Uma
Publisher:US: Oxford University Press
Journal title:Inflammatory bowel diseases, 2024-12, Vol.30 (12), p.2512-2515
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
S6 Pregnancy Outcomes in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis: Results From the Ozanimod Clinical Development Program
Author / Creator:Dubinsky, Marla C. ; Charles, Lorna ; Selmaj, Krzysztof W. ; Comi, Giancarlo ; Krakovich, Anthony ; Rosen, Melissa ; Van Der Woude, C. Janneke ; Mahadevan, Uma
Publisher:New York: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Journal title:The American journal of gastroenterology, 2023-12, Vol.118 (12S), p.S2-S3
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
S1161 Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis
Author / Creator:Dubinsky, Marla C. ; Charles, Lorna ; Selmaj, Krzysztof W. ; Comi, Giancarlo ; Krakovich, Anthony ; Janneke van der Woude, C. ; Mahadevan, Uma
Publisher:New York: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Journal title:The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S888-S888
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
The Heat Shock Protein HSP70 Promotes Th17 Genes' Expression via Specific Regulation of microRNA
Author / Creator:Cwiklinska, Hanna ; Cichalewska-Studzinska, Maria ; Selmaj, Krzysztof W ; Mycko, Marcin P
Publisher:Switzerland: MDPI AG
Journal title:International journal of molecular sciences, 2020-04, Vol.21 (8), p.2823
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
Author / Creator:Coles, Alasdair J ; Compston, D Alastair S ; Selmaj, Krzysztof W ; Lake, Stephen L ; Moran, Susan ; Margolin, David H ; Norris, Kim ; Tandon, P K
Publisher:Boston, MA: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2008-10, Vol.359 (17), p.1786-1801
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium ‘Non-coding RNAs in autoimmune disorders of the central nervous system’ on 5 April 2013 in Warsaw, Pola...
Author / Creator:Mycko, Marcin P ; Weiner, Howard L ; Selmaj, Krzysztof W
Publisher:London, England: SAGE Publications
Journal title:Multiple Sclerosis Journal, 2014-10, Vol.20 (11), p.1439-1442
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies
Author / Creator:Dayan, Colin M. ; Lecumberri, Beatriz ; Muller, Ilaria ; Ganesananthan, Sashiananthan ; Hunter, Samuel F. ; Selmaj, Krzysztof W. ; Hartung, Hans-Peter ; Havrdova, Eva K. ; LaGanke, Christopher C. ; Ziemssen, Tjalf ; Van Wijmeersch, Bart ; Meuth, Sven G. ; Margolin, David H. ; Poole, Elizabeth M. ; Baker, Darren P. ; Senior, Peter A.
Publisher:London, England: SAGE Publications
Journal title:Multiple sclerosis journal - experimental, translational and clinical, 2023-01, Vol.9 (1), p.20552173221142741-20552173221142741
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland
Author / Creator:Greve, Bernhard ; Simonenko, Rostislav ; Illes, Zsolt ; Peterfalvi, Agnes ; Hamdi, Nada ; Mycko, Marcin P ; Selmaj, Krzysztof W ; Rozsa, Csilla ; Rajczy, Katalin ; Bauer, Peter ; Berger, Klaus ; Weissert, Robert
Publisher:London, England: SAGE Publications
Journal title:Multiple sclerosis, 2008-03, Vol.14 (2), p.153-158
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
Author / Creator:Cohen, Jeffrey A ; Comi, Giancarlo ; Selmaj, Krzysztof W ; Bar-Or, Amit ; Arnold, Douglas L ; Steinman, Lawrence ; Hartung, Hans-Peter ; Montalban, Xavier ; Kubala Havrdová, Eva ; Cree, Bruce A C ; Sheffield, James K ; Minton, Neil ; Raghupathi, Kartik ; Huang, Vivian ; Kappos, Ludwig
Publisher:England: Elsevier Ltd
Journal title:Lancet neurology, 2019-11, Vol.18 (11), p.1021-1033
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
044 Durable clinical efficacy of alemtuzumab in patients with active rrms in the absence of continuous treatment: 7-year follow-up of CARE-MS I patients (Topaz Study)
Author / Creator:McCombe, Pamela ; Boyko, Alexey N ; DeSeze, Jérôme ; Hartung, Hans-Peter ; Havrdova, Eva ; Inshasi, Jihad Said ; Montalban, Xavier ; Pozzilli, Carlo ; Selmaj, Krzysztof W ; Vermersch, Patrick ; Melanson, Maria ; Daizadeh, Nadia ; Rodriguez, Claudio E ; Wijmeersch, Bart Van
Publisher:London: BMJ Publishing Group LTD
Journal title:Journal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A18-A19
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
2221 Evaluating no evidence of disease activity (NEDA) with Ozanimod in patients with relapsing multiple sclerosis (RMS): post hoc analysis of phase 3 RADIANCE and DAYBREAK
Author / Creator:Kappos, Ludwig ; Comi, Giancarlo ; Selmaj, Krzysztof W ; Steinman, Lawrence ; Bar-Or, Amit ; Arnold, Douglas L ; Hartung, Hans-Peter ; Montalbán, Xavier ; Havrdová, Eva K ; Pachai, Chahin ; Sheffield, James K ; Cheng, Chun-Yen ; Silva, Diego ; Vaile, John ; Morello, Jean Pierre ; Cohen, Jeffrey A ; Guevara-Harrison, Narelle ; Cree, Bruce AC
Publisher:London: BMJ Publishing Group Ltd
Journal title:BMJ neurology open, 2022-08, Vol.4 (Suppl 1), p.A18-A18
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system
Author / Creator:Selmaj, Krzysztof W
Publisher:BMJ Publishing Group Ltd
Journal title:Annals of the rheumatic diseases, 2000-11, Vol.59 (11), p.i94
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis
Author / Creator:Mycko, Marcin P ; Papoian, Ruben ; Boschert, Ursula ; Raine, Cedric S ; Selmaj, Krzysztof W
Publisher:Amsterdam: Elsevier B.V
Journal title:Clinical neurology and neurosurgery, 2004-06, Vol.106 (3), p.223-229
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 23 results

Search the collection

Export record to excel

Export this record

Export record to excel

microRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination

Export this record

Export record to excel

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Export this record

Export record to excel

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Export this record

Export record to excel

Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial

Export this record

Export record to excel

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial

Export this record

Export record to excel

Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes

Export this record

Export record to excel

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

Export this record

Export record to excel

Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis

Export this record

Export record to excel

S6 Pregnancy Outcomes in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis: Results From the Ozanimod Clinical Development Program

Export this record

Export record to excel

S1161 Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis

Export this record

Export record to excel

The Heat Shock Protein HSP70 Promotes Th17 Genes' Expression via Specific Regulation of microRNA

Export this record

Export record to excel

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

Export this record

Export record to excel

Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium ‘Non-coding RNAs in autoimmune disorders of the central nervous system’ on 5 April 2013 in Warsaw, Pola...

Export this record

Export record to excel

Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies

Export this record

Export record to excel

Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland

Export this record

Export record to excel

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

Export this record

Export record to excel

044 Durable clinical efficacy of alemtuzumab in patients with active rrms in the absence of continuous treatment: 7-year follow-up of CARE-MS I patients (Topaz Study)

Export this record

Export record to excel

2221 Evaluating no evidence of disease activity (NEDA) with Ozanimod in patients with relapsing multiple sclerosis (RMS): post hoc analysis of phase 3 RADIANCE and DAYBREAK

Export this record

Export record to excel

Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system

Export this record

Export record to excel

Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis

Refine your search